PharmaBlock (USA), Inc.

About

PharmaBlock (USA), Inc. is a contract development and manufacturing organization (CDMO) in the pharmaceutical industry, operating as a subsidiary of PharmaBlock Sciences. Established in 2012, the company has facilities in the Greater Philadelphia Area and Sunnyvale, California. It supports global partners throughout the drug discovery and commercialization process using advanced chemistry and green technologies. PharmaBlock offers a range of integrated services across the pharmaceutical R&D and manufacturing lifecycle. This includes a collection of over 200,000 high-quality building blocks, custom synthesis libraries, and GMP manufacturing of raw starting materials, intermediates, and active pharmaceutical ingredients. The company is recognized for its innovative technologies, such as flow chemistry and biocatalysis, which contribute to sustainable and cost-efficient solutions. PharmaBlock has partnered with many leading pharmaceutical companies and biotech firms, emphasizing its commitment to sustainability and efficient drug development processes.